ASTCHIGH SIGNALFINANCIAL10-K

ASTC experienced a substantial deterioration in financial performance with meaningfully reduced revenue, dramatically higher operating cash burn, and significant balance sheet contraction.

The company's revenue declined substantially while R&D expenses increased nearly 20%, creating a widening gap between spending and income generation that accelerated cash consumption. The dramatic reduction in inventory alongside revenue decline suggests potential demand challenges or strategic shifts in product positioning, particularly concerning given the company's mission-critical security applications.

Comparing 2025-09-26 vs 2024-09-20View on EDGAR →
FINANCIAL ANALYSIS

ASTC's financial position weakened considerably with revenue declining substantially to $1.0M while operating cash outflows increased meaningfully to $13.0M, indicating an unsustainable burn rate. The balance sheet contracted significantly with total assets falling 28% to $27.0M and stockholders' equity declining 37% to $22.1M, while total liabilities increased 73% to $4.9M. The near-complete inventory drawdown of 96% combined with higher capital expenditures suggests the company may be transitioning its product portfolio, but the widening losses raise questions about financial sustainability.

FINANCIAL STATEMENT CHANGES
Inventory
Balance Sheet
-95.8%
$166K→$7K

Inventory drawn down 95.8% — strong sell-through or deliberate destocking; watch for supply constraints.

Total Liabilities
Balance Sheet
+72.6%
$2.8M→$4.9M

Liabilities grew 72.6% — significant increase in debt or obligations, assess impact on financial flexibility.

Capital Expenditure
Cash Flow
+43.9%
$579K→$833K

Capital expenditure jumped 43.9% — major investment cycle underway; assess returns on deployment.

Revenue
P&L
-41.2%
$1.7M→$1.0M

Revenue declined 41.2% — significant demand weakness or market share loss warrants investigation.

Gross Profit
P&L
-36.8%
$751K→$475K

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Current Assets
Balance Sheet
-36.7%
$34.7M→$22.0M

Current assets declined 36.7% — monitor working capital adequacy and short-term liquidity.

Stockholders Equity
Balance Sheet
-36.5%
$34.8M→$22.1M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Operating Cash Flow
Cash Flow
-33.2%
-$9.7M→-$13.0M

Operating cash flow fell 33.2% — earnings quality concerns; investigate working capital changes and non-cash items.

Total Assets
Balance Sheet
-28.3%
$37.6M→$27.0M

Total assets contracted 28.3% — asset sales, write-downs, or balance sheet optimization underway.

R&D Expense
P&L
+19.9%
$6.8M→$8.1M

R&D investment increased 19.9% — signals commitment to future product development, though near-term margin impact.

LANGUAGE CHANGES
NEW — 2025-09-26
PRIOR — 2024-09-20
ADDED
As of September 24, 2025, 1,758,953 shares of the registrant s common stock, par value $0.001 per share, were issued and outstanding.
Such risks and uncertainties include, but are not limited to: The adverse expectations regarding the global economy, inflation, the potential for recession and geopolitical tensions and any resulting sanctions, or wars; The effect of economic and political conditions in the United States or other nations that could impact our ability to sell our products and services or gain customers; Product demand and market acceptance risks, including our ability to develop and sell products and services to be used by governmental or commercial customers; The impact of trade barriers imposed by the U.S.
Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of the assumptions could be inaccurate.
Our mission encompasses the advancement of both mass spectrometry and gas chromatography, two powerful analytical techniques that together enable precise detection and identification of chemical compounds across a wide range of high-demand environments.
We aim to expand access to mass spectrometry by simplifying the complexity of operating these devices within real-time testing environments such as airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, law enforcement centers, and industrial locations.
+7 more — sign up free →
REMOVED
As of September 17, 2024, 1,701,729 shares of the registrant s common stock, par value $0.001 per share, were outstanding.
Our mission is to expand access to mass spectrometry ( MS ) and its use through the deployment of devices designed specifically for the appropriate levels of precision required in high-volume, real-time testing environments such as airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, law enforcement centers, and industrial locations.
We achieve our mission through simplifying the user interface, automating the complicated calibration process, ruggedizing the critical components to endure MS field work, and enabling multiple configurations for sample intake options.
Since the Tracer 1000 was certified by the European Civil Aviation Conference ( ECAC ) in 2019, our customers have deployed our devices in approximately 30 locations across 14 countries throughout Europe and Asia.
( Pro-Control ) is focused on applying the AMS Technology in industrial process control applications.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →